Home›Companies›Healthcare›Moximed

Moximed, Inc

Updated Oct 27, 2026·Latest SEC filing Aug 20, 2024·Suggest an edit

About Moximed

Moximed is a private company based in Fremont, California. It has reported $187,834,993 raised in five offerings on Form D since August 2009. Its chief executive is Christopher Gleason.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Aug 7, 2024Aug 20, 2024$62,712,862of $91.0M target35$1.7MEquityRule 506(b)Form D ↗
Mar 15, 2017Mar 31, 2017$49,541,720of $51.4M target8$6.1MEquityRule 506(b)Form D ↗
Apr 23, 2015May 5, 2015$19,742,755of $37.6M target104$189KEquity, OptionsRule 506(b)Form D ↗
May 26, 2011Jun 7, 2011amended Dec 5, 2011$45,837,656of $45.8M target55$833KEquity06Form D/A ↗1 earlier filing
Aug 5, 2009Aug 14, 2009$10,000,000of $11.0M target2$5.0MEquity06Form D ↗
Total, five offerings$187,834,993

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Moximed's Form D filed Aug 20, 2024.

DA
SM
DM
David van Meter
Director
Also a director at Nuvaira.
MM
AC
Anton Clifford
Executive officer
James Leech
James Leech
Executive officer
Also a chief financial and strategy officer at Gt Medical Technologies.

Earlier filings also listed Ryan Drant (director, last listed Mar 2017), Robert Croce (director, last listed Mar 2017), Robert Anderson (director, last listed Mar 2017), Kevin Sidow (president/ceo and director, last listed Mar 2017), Henry Plain, Jr. (director, last listed Mar 2017), Dan Murray (chief financial officer, last listed Mar 2017), Christopher Shen (director, last listed Mar 2017) and Arthur Franken (director, last listed Mar 2017).

Sources

  1. SECMoximed, Inc Form D, filed Jun 7, 2011
  2. SECMoximed, Inc filing history